How does Sitagliptin compare with insulin pumps in controlling glycemic variability, and what are the advantages or limitations of each approach?
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Sitagliptin compare with insulin pumps in controlling glycemic variability, and what are the advantages or limitations of each approach?
Sitagliptin, an oral antidiabetic, improves glycemic control by enhancing insulin secretion. Unlike insulin pumps that provide continuous insulin, it doesn’t directly lower glucose but reduces glucose fluctuations.
Insulin pumps offer precise control over blood glucose by delivering continuous insulin, adaptable to real-time needs. Sitagliptin is less invasive, but pumps may better manage severe diabetes with high glycemic variability.